171 related articles for article (PubMed ID: 29507674)
1. Comparison of Immuno-PET of CD138 and PET imaging with
Bailly C; Gouard S; Lacombe M; Remaud-Le Saëc P; Chalopin B; Bourgeois M; Chouin N; Tripier R; Halime Z; Haddad F; Faivre-Chauvet A; Kraeber-Bodéré F; Chérel M; Bodet-Milin C
Oncotarget; 2018 Feb; 9(10):9061-9072. PubMed ID: 29507674
[TBL] [Abstract][Full Text] [Related]
2. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
3. TE1PA as Innovating Chelator for
Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A
Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
Soodgupta D; Zhou H; Beaino W; Lu L; Rettig M; Snee M; Skeath J; DiPersio JF; Akers WJ; Laforest R; Anderson CJ; Tomasson MH; Shokeen M
J Nucl Med; 2016 Apr; 57(4):640-5. PubMed ID: 26742713
[TBL] [Abstract][Full Text] [Related]
6. New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
Org Biomol Chem; 2015 Dec; 13(46):11302-14. PubMed ID: 26419637
[TBL] [Abstract][Full Text] [Related]
7. Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.
Soodgupta D; Hurchla MA; Jiang M; Zheleznyak A; Weilbaecher KN; Anderson CJ; Tomasson MH; Shokeen M
PLoS One; 2013; 8(2):e55841. PubMed ID: 23409060
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of a
Métivier C; Le Saëc P; Gaschet J; Chauvet C; Marionneau-Lambot S; Hofgaard PO; Bogen B; Pineau J; Le Bris N; Tripier R; Alliot C; Haddad F; Chérel M; Chouin N; Faivre-Chauvet A; Rbah-Vidal L
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514004
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
10. Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model.
Fichou N; Gouard S; Maurel C; Barbet J; Ferrer L; Morgenstern A; Bruchertseifer F; Faivre-Chauvet A; Bigot-Corbel E; Davodeau F; Gaschet J; Chérel M
Front Med (Lausanne); 2015; 2():76. PubMed ID: 26582128
[TBL] [Abstract][Full Text] [Related]
11. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of C-functionalized TE1PA and comparison with its analogues. An example of bioconjugation on 9E7.4 mAb for multiple myeloma
Le Bihan T; Navarro AS; Le Bris N; Le Saëc P; Gouard S; Haddad F; Gestin JF; Chérel M; Faivre-Chauvet A; Tripier R
Org Biomol Chem; 2018 Jun; 16(23):4261-4271. PubMed ID: 29701218
[TBL] [Abstract][Full Text] [Related]
13. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
14. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
[TBL] [Abstract][Full Text] [Related]
15. Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in A Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.
Gouard S; Maurel C; Marionneau-Lambot S; Dansette D; Bailly C; Guérard F; Chouin N; Haddad F; Alliot C; Gaschet J; Eychenne R; Kraeber-Bodéré F; Chérel M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32971984
[TBL] [Abstract][Full Text] [Related]
16. Interest of Pet Imaging in Multiple Myeloma.
Jamet B; Bailly C; Carlier T; Touzeau C; Nanni C; Zamagni E; Barré L; Michaud AV; Chérel M; Moreau P; Bodet-Milin C; Kraeber-Bodéré F
Front Med (Lausanne); 2019; 6():69. PubMed ID: 31024917
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
18. Reactor produced [
Chakravarty R; Shetty P; Nair KVV; Rajeswari A; Jagadeesan KC; Sarma HD; Rangarajan V; Krishnatry R; Chakraborty S
Ann Nucl Med; 2020 Dec; 34(12):899-910. PubMed ID: 33048309
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [
Stokke C; Nørgaard JN; Feiring Phillips H; Sherwani A; Nuruddin S; Connelly J; Schjesvold F; Revheim ME
Mol Imaging Biol; 2022 Oct; 24(5):842-851. PubMed ID: 35501622
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
Wagner M; Wuest M; Hamann I; Lopez-Campistrous A; McMullen TPW; Wuest F
Nucl Med Biol; 2018 Mar; 58():51-58. PubMed ID: 29367096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
